The Evolution of Intracranial Hemorrhage Management

Authors

• Oleg Yermakov, University of LynchburgFollow

Specialty

Neurology

Abstract

The objective of this article is to provide a comprehensive review of the current evidence surrounding the diagnosis and management of spontaneous intracerebral hemorrhage (ICH), the most lethal subtype of stroke. Despite representing 10–15% of all strokes, ICH carries a 30-day mortality rate of around 40%, and survivors often experience significant long-term neurological and functional deficits. This review highlights the primary risk factors for ICH, including arteriolosclerosis, cerebral amyloid angiopathy, and anticoagulant and antiplatelet therapy. Clinical presentation typically involves acute focal neurological deficits along with headache and altered mental status. Prompt neuroimaging with non-contrast CT is essential for timely diagnosis and management. A systematic literature search was conducted using PubMed, MEDLINE, and Google Scholar from 2016 to 2026. Several landmark studies conducted before 2019 were included, as they are essential to ICH research. Studies included randomized controlled trials, meta-analyses, and systematic reviews relevant to the diagnosis of spontaneous ICH, medical management, and surgical interventions.

Medical management strategies focus on limiting hematoma expansion by rapidly controlling blood pressure and reversing anticoagulant or antiplatelet agents. The ENRICH trial has demonstrated that surgical approaches, especially minimally invasive techniques, have evolved to improve functional outcomes. Emerging diagnostic methods, including prehospital biomarkers such as glial fibrillary acidic protein (GFAP) and AI-assisted CT interpretation, show promise in reducing the time to treatment by shortening diagnostic delays. Despite these advances, variability in study designs and patient populations remains a challenge, highlighting the need for ongoing research to optimize both medical and surgical management strategies. In conclusion, ICH requires prompt recognition, diagnosis, stabilization, and intervention to reduce morbidity and mortality. Integrating current evidence-based medical and surgical practices with novel diagnostic innovations has the potential to significantly improve patient outcomes and reduce the global burden of this devastating condition.

Recommended Citation

Yermakov O. The Evolution of Intracranial Hemorrhage Management. University of Lynchburg DMSc Doctoral Project Assignment Repository. 2026; 8(1).